Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Health Benefits of Dance Exercise

9. Juni 2026 aktualisiert von: Dimitrios Draganidis, University of Thessaly

Effects of a 6-month Dance Exercise Intervention on Physical Performance, Metabolic and Mental Health in Pre- and Post-menopausal Women

In Greece, people of different age groups, including young children to older adults, participate in dance exercise training. Although it is well-known that regular participation in dancing is associated with benefits such as entertainment, socialization and increased physical activity, the long-term effects of dancing on metabolic and mental health as well as physical performance remain largely unknown. Therefore, the aim of this study is to investigate the effects of a 6-month dancing exercise intervention on metabolic and mental health and physical performance in premenopausal and postmenopausal women.

Studienübersicht

Status

Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Twenty premenopausal and twenty postmenopausal inactive women meeting the inclusion criteria will be randomly assigned to a Control (n=20) or an Experimental group (n=20). The Control group will maintain their habitual physical activity level without participating in any form of exercise training. The Experimental group will participate in two weekly dance exercise training sessions over a 6-month period. Each session will be performed under supervision and include a 10-min warm up (2-3 dances of very slow tempo), a 45-min main dance exercise session (~15 dances of various tempos i.e. slow, moderate and fast tempo) and a 5-min cool-down period (walking and stretching). Heart rate will be continuously monitored during each session by using heart rate monitors while the rate of perceived exertion (RPE) will be recorded at the end of each session. In addition, prior to the second dance exercise session in each week, participants' delayed onset of muscle soreness (DOMS) and wellness status (through the wellness report) will be evaluated. Prior to (Baseline) and after the intervention period (at 6 months) participants of both groups (Control and Experimental) will undergo resting blood sampling and assessment of their (i) anthropometrics, (ii) body composition, (iii) physical performance, (iv) physical activity level, (v) dietary intake, (vi) quality of life and (vii) mental health.

Studientyp

Interventionell

Einschreibung (Geschätzt)

40

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Dimitrios Draganidis, PhD
  • Telefonnummer: +30 2431047047
  • E-Mail: ddraganidis@uth.gr

Studieren Sie die Kontaktsicherung

  • Name: Ioannis G Fatouros, PhD
  • Telefonnummer: + 30 2431047047
  • E-Mail: ifatouros@uth.gr

Studienorte

  • Griechenland
    • Karies
      • Trikala, Karies, Griechenland, 42100
        • Rekrutierung
        • Department of Physical Education and Sport Science, University of Thessaly
        • Kontakt:
          • Ioannis G Fatouros, PhD
          • Telefonnummer: +30 24310 47047
          • E-Mail: ifatouros@uth.gr
        • Kontakt:
          • Athanasios Z Jamurtas, PhD
          • Telefonnummer: +30 2431047054
          • E-Mail: ajamurt@uth.gr

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Free of musculoskeletal injuries
  • Free of chronic non-communicable diseases
  • Normal menstrual cycle (for premenopausal women)
  • No recent childbirth (previous 12 months) (for premenopausal women)
  • At least 12 months since the oncet of menopause (for postmenopausal women)
  • Non smokers

Exclusion Criteria:

  • Pregnancy (for premenopausal women)
  • Contraindications to exercise training
  • Illness or other medical condition
  • Use of medication

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Control Group
Participants in this group will maintain their habitual physical activity level without participating in any form of exercise training
Sonstiges: No exercise training
It will include only habitual physical activity level without participating in any form of exercise training
Experimental: Experimental Group
Participants in this group will participate in two weekly dance exercise training sessions over a 6-month period
Sonstiges: Exercise training
This intervention will consist of two weekly dance exercise training sessions over a 6-month period. Each session will be performed under supervision and include a 10-min warm up (2-3 dances of very slow tempo), a 45-min main dance exercise session (~15 dances of various tempos i.e. slow, moderate and fast tempo) and a 5-min cool-down period (walking and stretching)

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in glucose concentration
Zeitfenster: At baseline and 6 months
Fasting glucose concentration will be determined in blood
At baseline and 6 months
Change in insulin concentration
Zeitfenster: At baseline and 6 months
Fasting insulin concentration will be determined in blood
At baseline and 6 months
Change in total cholesterol concentration
Zeitfenster: At baseline and 6 months
Total cholesterol concentration will be determined in blood
At baseline and 6 months
Change in HDL cholesterol concentration
Zeitfenster: At baseline and 6 months
HDL cholesterol concentration will be determined in blood
At baseline and 6 months
Change in LDL cholesterol concentration
Zeitfenster: At baseline and 6 months
LDL cholesterol concentration will be determined in blood
At baseline and 6 months
Change in triglycerides concentration
Zeitfenster: At baseline and 6 months
Triglycerides concentration will be determined in blood
At baseline and 6 months
Change in serum glutamic-oxaloacetic transaminase (SGOT/AST) concentration
Zeitfenster: At baseline and 6 months
SGOT concentration will be determined in blood
At baseline and 6 months
Change in alanine aminotransferase (SGPT/ALT) concentration
Zeitfenster: At baseline and 6 months
SGPT concentration will be determined in blood
At baseline and 6 months
Change in gamma-glutamyl transpeptidase (γ-GT) concentration
Zeitfenster: At baseline and 6 months
γ-GT concentration will be determined in blood
At baseline and 6 months
Change in body weight
Zeitfenster: At baseline and 6 months
At baseline and 6 months
Change in waist circumference
Zeitfenster: At baseline and 6 months
At baseline and 6 months
Change in hip circumference
Zeitfenster: At baseline and 6 months
At baseline and 6 months
Change in cardiorespiratory fitness
Zeitfenster: At baseline and 6 months
Cardiorespiratory fitness will be assessed using the Ebbeling single stage treadmill test
At baseline and 6 months
Change in muscle endurance
Zeitfenster: At baseline and 6 months
Muscle endurance will be assessed using the push-up and curl-up testing protocols
At baseline and 6 months
Change in resting blood pressure
Zeitfenster: At baseline and 6 months
Resting systolic and diastolic blood pressure will be assessed using a sphygmomanometer
At baseline and 6 months
Change in quality of life
Zeitfenster: At baseline and 6 months
Quality of life will be evaluated using questionnaire
At baseline and 6 months
Change in vitality
Zeitfenster: At baseline and 6 months
Vitality will be evaluated using questionnaire
At baseline and 6 months
Change in anxiety level
Zeitfenster: At baseline and 6 months
Anxiety will be evaluated using questionnaire
At baseline and 6 months
Change in flourishing
Zeitfenster: At baseline and 6 months
Flourishing will be evaluated using questionnaire
At baseline and 6 months
Change in fat mass
Zeitfenster: At baseline and 6 months
Fat mass will be assessed using whole-body dual-energy X-ray absorptiometry (DXA)
At baseline and 6 months
Change in body fat percentage (%)
Zeitfenster: At baseline and 6 months
Body fat percentage (%) will be assessed using whole-body dual-energy X-ray absorptiometry (DXA)
At baseline and 6 months
Change in fat free mass
Zeitfenster: At baseline and 6 months
Fat free mass will be assessed using whole-body dual-energy X-ray absorptiometry (DXA)
At baseline and 6 months
Change in lean body mass
Zeitfenster: At baseline and 6 months
Lean body mass will be assessed using whole-body dual-energy X-ray absorptiometry (DXA)
At baseline and 6 months
Change in functional performance
Zeitfenster: At baseline and 6 months
Functional performance will be assessed using the Short Physical Performance Battery
At baseline and 6 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in dietary intake
Zeitfenster: At baseline and 6 months
Dietary intake will be monitored using diet recalls
At baseline and 6 months
Change in daily number of steps
Zeitfenster: At baseline and 6 months
Daily number of steps performed will be assessed using accelerometers
At baseline and 6 months
Change in daily time spent in moderate-to-vigorous physical activity
Zeitfenster: At baseline and 6 months
The time spent in moderate-to-vigorous physical activity will be assessed using accelerometers
At baseline and 6 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

University of Thessaly

Ermittler

  • Hauptermittler: Maria Bougiesi, PhD, University of Thessaly, Department of Physical Education and Sport Science

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

30. Mai 2026

Primärer Abschluss (Geschätzt)

30. November 2026

Studienabschluss (Geschätzt)

20. Dezember 2026

Studienanmeldedaten

Zuerst eingereicht

22. Mai 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

22. Mai 2026

Zuerst gepostet (Tatsächlich)

29. Mai 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

12. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

9. Juni 2026

Zuletzt verifiziert

1. Mai 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • UTH_2251_Long term

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Psychische Gesundheit

Klinische Studien zur No exercise training

Suchen Sie nach ähnlichen Studien

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

CROs by country

CROs in Kyrgyzstan

Bedingungen

Seltene Krankheiten

Drogeninterventionen

Nahrungsergänzungsmittel

Sponsor / Mitarbeiter

Standorte

Abonnieren